Sexual functions of female patients with chronic liver disease from two centers in Nigeria

• Main Authors: Olusegun Adekanle, Samuel Anu Olowookere, Oluwasegun Ijarotimi, Dennis Ndububa, Oladele Oluwafemi Ayodeji
• Format: Article
• Language: Arabic
• Published: Wolters Kluwer Medknow Publications 2018-01-01
• Series: Libyan International Medical University Journal
• Subjects: Chronic liver disease; females; Nigeria; sexual functions
• Online Access: http://journal.limu.edu.ly/article.asp?issn=2519-139x;year=2018;volume=3;issue=2;spage=59;epage=64;aulast=Adekanle

Background: Chronic liver disease (CLD) is a disease with significant morbidity and mortality in Nigeria. This study assessed the sexual functions of women with chronic hepatitis B infection (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC) designated as cases and normal women as controls. Methods: A prospective, comparative, case–control study of CHB, LC, HCC, and controls. Consenting cases and controls completed a self-administered Female Sexual Function Questionnaire (FSFI). Bio-data was obtained for all participants and cases were graded using the Child–Turcotte–Pugh scores (CTP). Data obtained were entered into SPSS version 20 and analyzed using descriptive and inferential statistics. Results: A total of 176 women completed the study, comprising 88 cases and 88 controls. Mean age (standard deviation) was 39.5 + 8.5 years and 40.5 + 8.2 years for cases and controls, respectively. Cases comprised CHB – 46, LC – 25, and HCC – 17, and their CTP classes were CTP A, 54; CTP B, 22; and CTP C, 12. The FSFI scores for CHB compared with controls were not statistically significant in all domains of the FSFI. The FSFI scores for LC and HCC in all domains were statistically significant compared with controls. Total mean FSFI scores for cases in CTP Class C showed sexual dysfunction, where 13.6% of CLD and 6.8% of all participants had sexual dysfunction and none among the controls. Conclusions: Females with advanced CLD had sexual dysfunction. Sexual concerns of females with CLD should be inquired for and treated.